Showing results (41-50 of 116) with videos related to
Sort By:
Pageof 12
Frontiers in Oncology|November 9, 2018
Developments in Blood-Brain Barrier Penetrance and Drug Repurposing for Improved Treatment of GlioblastomaBryan G Harder, Mylan R Blomquist, Junwen Wang, et al.Journal of Neuro-Oncology|November 13, 2015
Propentofylline inhibits glioblastoma cell invasion and survival by targeting the TROY signaling pathwayHarshil D Dhruv, Alison Roos, Patrick J Tomboc, et al.Cancer Letters|July 11, 2014
LKB1 inactivation sensitizes non-small cell lung cancer to pharmacological aggravation of ER stressLandon J Inge, Jacqueline M Friel, Amanda L Richer, et al.Molecular Cancer|September 13, 2012
The small GTPase RhoG mediates glioblastoma cell invasionAneta Kwiatkowska, Sebastien Didier, Shannon Fortin, et al.Medrxiv : the Preprint Server for Health Sciences|January 3, 2024
Revealing the biology behind MRI signatures in high grade gliomaErika M Lewis, Lingchao Mao, Lujia Wang, et al.Plos One|August 23, 2013
Reciprocal activation of transcription factors underlies the dichotomy between proliferation and invasion of glioma cellsHarshil D Dhruv, Wendy S McDonough Winslow, Brock Armstrong, et al.Neoplasia (New York, N.Y.)|September 17, 2018
PDZ-RhoGEF Is a Signaling Effector for TROY-Induced Glioblastoma Cell Invasion and SurvivalZonghui Ding, Harshil Dhruv, Aneta Kwiatkowska-Piwowarczyk, et al.Translational Lung Cancer Research|March 26, 2015
Molecular determinants of lung cancer metastasis to the central nervous systemTimothy G Whitsett, Landon J Inge, Harshil D Dhruv, et al.The American Journal of Pathology|November 15, 2008
The guanine nucleotide exchange factors trio, Ect2, and Vav3 mediate the invasive behavior of glioblastomaBodour Salhia, Nhan L Tran, Amanda Chan, et al.Neuro-Oncology|June 14, 2018
The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistanceDavid S Hersh, Bryan G Harder, Alison Roos, et al.Pageof 12